Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

The Role of Gay-Related Stigma in HIV-Risk Behavior Among Sexual Minority Men in Europe.

Leluţiu-Weinberger C, Rendina HJ, Mirandola M, Gios L, Folch C, Rafila A, Pachankis JE.

AIDS Behav. 2018 Oct 9. doi: 10.1007/s10461-018-2306-z. [Epub ahead of print]

PMID:
30302655
2.

The UALE project: a cross-sectional approach for trends in HIV/STI prevalence among key populations attending STI clinics in Guatemala.

García JI, Sabidó M, Nikiforov M, Smith A, Hernández G, Ortiz R, Ardani L, Cajas A, Camey E, Torrelles JB, Wang SH, Campbell CNJ, Folch C, Casabona J; UALE Study Group.

BMJ Open. 2018 Sep 19;8(9):e022632. doi: 10.1136/bmjopen-2018-022632.

3.

Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey.

Rosińska M, Gios L, Nöstlinger C, Vanden Berghe W, Marcus U, Schink S, Sherriff N, Jones AM, Folch C, Dias S, Velicko I, Mirandola M; Sialon II Network.

Int J Drug Policy. 2018 May;55:231-241. doi: 10.1016/j.drugpo.2018.01.002. Epub 2018 May 7.

PMID:
29402683
4.

Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain and Barnaul, Russia.

Folch C, Zohrabyan L, Vagaitseva N, Casabona J, Toskin I; local REDAN Group.

BMC Public Health. 2018 Jan 29;18(1):187. doi: 10.1186/s12889-018-5065-x.

5.

HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study.

Marcus U, Schink SB, Sherriff N, Jones AM, Gios L, Folch C, Berglund T, Nöstlinger C, Niedźwiedzka-Stadnik M, Dias SF, Gama AF, Naseva E, Alexiev I, Staneková D, Toskin I, Pitigoi D, Rafila A, Klavs I, Mirandola M; Sialon II Network.

BMC Infect Dis. 2017 Nov 25;17(1):730. doi: 10.1186/s12879-017-2814-x.

6.

Is systematic training in opioid overdose prevention effective?

Espelt A, Bosque-Prous M, Folch C, Sarasa-Renedo A, Majó X, Casabona J, Brugal MT; REDAN Group.

PLoS One. 2017 Oct 31;12(10):e0186833. doi: 10.1371/journal.pone.0186833. eCollection 2017.

7.

Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of key populations in Barcelona, Spain.

Saludes V, Folch C, Morales-Carmona A, Ferrer L, Fernàndez-López L, Muñoz R, Jiménez M, Loureiro E, Fernández-Dávila P, Bascuñana E, Casabona J, Martró E.

J Viral Hepat. 2018 Mar;25(3):236-244. doi: 10.1111/jvh.12809. Epub 2017 Dec 9.

PMID:
29053912
8.

A typology of female sex work in the Metropolitan Region of Santiago, Chile.

Belmar J, Stuardo V, Folch C, Carvajal B, Clunes MJ, Montoliu A, Casabona J.

Cult Health Sex. 2018 Apr;20(4):428-441. doi: 10.1080/13691058.2017.1355478. Epub 2017 Aug 11.

PMID:
28799462
9.

Undiagnosed HIV and Hepatitis C infection in people who inject drugs: From new evidence to better practice.

Parés-Badell O, Espelt A, Folch C, Majó X, González V, Casabona J, Brugal MT.

J Subst Abuse Treat. 2017 Jun;77:13-20. doi: 10.1016/j.jsat.2017.03.003. Epub 2017 Mar 9.

PMID:
28476265
10.

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Wiessing L, Ferri M, Běláčková V, Carrieri P, Friedman SR, Folch C, Dolan K, Galvin B, Vickerman P, Lazarus JV, Mravčík V, Kretzschmar M, Sypsa V, Sarasa-Renedo A, Uusküla A, Paraskevis D, Mendão L, Rossi D, van Gelder N, Mitcheson L, Paoli L, Gomez CD, Milhet M, Dascalu N, Knight J, Hay G, Kalamara E, Simon R; EUBEST working group, Comiskey C, Rossi C, Griffiths P.

Harm Reduct J. 2017 Apr 22;14(1):19. doi: 10.1186/s12954-017-0141-6.

11.

[Survey adaptation for bio-behavioural surveillance of HIV in Chilean female sex workers].

Carvajal B, Stuardo V, Manríquez JM, Belmar J, Folch C.

Gac Sanit. 2017 Nov - Dec;31(6):478-484. doi: 10.1016/j.gaceta.2016.10.010. Epub 2017 Apr 12. Spanish.

12.

Differences between migrants and Spanish-born population through the HIV care cascade, Catalonia: an analysis using multiple data sources.

Reyes-Urueña J, Campbell C, Hernando C, Vives N, Folch C, Ferrer L, Fernández-López L, Esteve A, Casabona J.

Epidemiol Infect. 2017 Jun;145(8):1670-1681. doi: 10.1017/S0950268817000437. Epub 2017 Mar 8.

PMID:
28270252
13.

Highly sensitive LC-MS/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application.

Canal-Raffin M, Khennoufa K, Martinez B, Goujon Y, Folch C, Ducint D, Titier K, Brochard P, Verdun-Esquer C, Molimard M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 21. pii: S1570-0232(16)31088-1. doi: 10.1016/j.jchromb.2016.10.021. [Epub ahead of print]

PMID:
28029545
14.

Socio-demographic factors predicting HIV test seeking behaviour among MSM in 6 EU cities.

Mirandola M, Gios L, Joanna Davis R, Furegato M, Breveglieri M, Folch C, Staneková D, Nita I, Stehlíková D.

Eur J Public Health. 2017 Apr 1;27(2):313-318. doi: 10.1093/eurpub/ckw144.

PMID:
27615734
15.

Erratum to: Awareness of Pre-exposure Prophylaxis for HIV, Willingness to Use It and Potential Barriers or Facilitators to Uptake Among Men Who Have Sex with Men in Spain.

Ferrer L, Folch C, Fernandez-Davila P, Garcia A, Morales A, Belda J, Susperregui AR, Casabona J; Ad hoc study group for PrEP acceptability.

AIDS Behav. 2016 Jul;20(7):1434. No abstract available.

PMID:
27262874
16.

[Erratum to «High prevalence of drug consumption and sexual risk behaviors in men who have sex with men»].

Folch C, Fernández-Dávila P, Ferrer L, Soriano R, Díez M, Casabona J.

Med Clin (Barc). 2016 Jul 1;147(1):47. doi: 10.1016/j.medcli.2016.03.010. Epub 2016 Apr 12. Spanish. No abstract available.

PMID:
27084559
17.

Awareness of Pre-exposure Prophylaxis for HIV, Willingness to Use It and Potential Barriers or Facilitators to Uptake Among Men Who Have Sex with Men in Spain.

Ferrer L, Folch C, Fernandez-Davila P, Garcia A, Morales A, Belda J, Susperregui AR, Casabona J; Ad hoc study group for PrEP acceptability.

AIDS Behav. 2016 Jul;20(7):1423-33. doi: 10.1007/s10461-016-1379-9. Erratum in: AIDS Behav. 2016 Jul;20(7):1434.

PMID:
27022938
18.

Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.

Fernàndez-López L, Folch C, Majó X, Gasulla L, Casabona J.

AIDS Care. 2016;28(6):712-6. doi: 10.1080/09540121.2016.1164290. Epub 2016 Mar 23.

PMID:
27007000
19.

Bio-behavioural HIV and STI surveillance among men who have sex with men in Europe: the Sialon II protocols.

Gios L, Mirandola M, Toskin I, Marcus U, Dudareva-Vizule S, Sherriff N, Breveglieri M, Furegato M, Folch C, Ferrer L, Montoliu A, Nöstlinger C, Vanden Berghe W, Kühlmann-Berenzon S, Velicko I, Dias S, Suligoi B, Regine V, Stanekova D, Rosińska M, Caplinskas S, Klavs I, Alexiev I, Rafila A.

BMC Public Health. 2016 Mar 2;16:212. doi: 10.1186/s12889-016-2783-9.

20.

High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?

Folch C, Casabona J, Espelt A, Majó X, Meroño M, Gonzalez V, Wiessing L, Colom J, Brugal MT; REDAN Study Group.

Subst Use Misuse. 2016 Jan 28;51(2):250-60. doi: 10.3109/10826084.2015.1092991. Epub 2016 Jan 28.

PMID:
26820260

Supplemental Content

Support Center